BioControl secures £500,000
BioControl, a UK-based company developing a phage based treatment for pseudomonas aeruginosa infections, has raised £500,000 in its first institutional round.
News
BioControl, a UK-based company developing a phage based treatment for pseudomonas aeruginosa infections, has raised £500,000 in its first institutional round.
News
Partner content
Accounting and Finance Software
Accounting and Finance Software